Relationship between tumor vascularity and vascular endothelial growth factor as prognostic factors for patients with neuroblastoma.

Abstract

Although the role of angiogenesis in tumor progression and response to treatment is generally well-characterized, for neuroblastomas clinical data regarding the contribution of angiogenesis and its predictive capacity remain unclear. The aim of this study was to evaluate whether tumor vascularity in the combination with expression of vascular endothelial growth factor (VEGF) represent prognostic factors for patients with neuroblastoma. Immunohistochemistry using anti-CD34 and anti-VEGF antibodies was used to analyze paraffin-embedded primary tumor tissues from 56 patients diagnosed with neuroblastoma. Tumor vascularity was estimated by calculating the tumor vascular volume fraction (TVVF), and VEGF expression was determined using semi-quantitative scoring. Statistical analyses including multivariate analysis were performed and compared with these two factors. Tumor vascularity had impact on survival of high VEGF expression neuroblastoma patients. Combination of high VEGF expression and TVVF value < or = 5% was independent predictor of overall survival (p-value = 0.0041, odds ratio (OR) (95% CI) = 8.67 (1.99-37.69) by the Cox proportional hazards model). This study revealed for the first time a group of extremely high-risk neuroblastoma with both high VEGF expression and poor vascularity. For these patients reduced rates of survival were observed (37% vs. 92.5%) (p < 0.0001). These patients did not experience a significant improvement following hematopoietic stem cell transplantation, and could be candidates for receiving novel therapies. These results indicate the importance of the mutual relationship between tumor vascularity and VEGF, because it gives better insight into the prognosis of patients with neuroblastoma.

• Authors: Gordana Jakovljević, Srdana Culić, Jasminka Stepan, Iva Kosuta, Sven Seiwerth
• Journal: Collegium antropologicum (Coll Antropol) Vol. 35 Issue 4 Pg. 1071-9 (Dec 2011) ISSN: 0350-6134 [Print] Croatia
• PMID: 22397241 (Publication Type: Journal Article)

Chemical References

• Antigens, CD34
• Vascular Endothelial Growth Factor A

Topics

• Antigens, CD34 (analysis)
• Child
• Child, Preschool
• Female
• Humans
• Infant
• Male
• Neovascularization, Pathologic
• Neuroblastoma (blood supply, mortality)
• Prognosis
• Survival Rate
• Vascular Endothelial Growth Factor A (analysis)